Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neurodegenerative disease company Alector raises $10mm in Series A round

Executive Summary

Polaris Venture Partners and OrbiMed Advisors led a Series A financing for Alector LLC (antibodies for neurodegenerative diseases) and each contribute two board members. NOTE: According to a secondary industry source, the amount of the Series A financing was $10mm.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies